Instrument Inactif

Cours CoLucid Pharmaceuticals Inc

Actions

Cours en clôture Nasdaq
- ^USD	-

01/03/17	CoLucid Pharmaceuticals : Lilly Completes Acquisition of CoLucid Pharmaceuticals
02/02/17	Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of CoLucid Pharmaceuticals, Inc. to Eli Lilly & Co. for $46.50 Per Share is Fair to Shareholders
31/01/17	Bragar Eagel & Squire, P.C. : Is Investigating the Board of Directors of CoLucid Pharmaceuticals, Inc. (CLCD) on Behalf of Stockholders and Encourages Investors to Contact the Firm
30/01/17	Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
27/01/17	Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of CoLucid Pharmaceuticals, Inc. to Eli Lilly & Co. for $46.50 Per Share is Fair to Shareholders -- CLCD

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
ELI LILLY AND COMPANY	-1,12%	-5,49%	+60,19%	+112,43%	1 048 Md
JOHNSON & JOHNSON	-1,57%	-0,60%	+50,33%	+59,86%	640 Md
ABBVIE INC.	-1,81%	-1,41%	+24,07%	+75,98%	456 Md
ROCHE HOLDING AG	-0,21%	-3,22%	+39,27%	+40,27%	362 Md
NOVARTIS AG	+0,06%	-2,06%	+22,91%	+37,96%	295 Md
ASTRAZENECA PLC	+0,27%	+0,75%	+2,26%	+12,37%	255 Md
AMGEN INC.	-0,76%	+0,75%	+51,75%	+70,45%	236 Md
NOVO NORDISK A/S	+1,59%	-0,32%	-16,42%	-53,61%	204 Md
GILEAD SCIENCES, INC.	+0,52%	+3,78%	+30,67%	+93,68%	185 Md
Moyenne	-0,35%	-0,72%	+29,45%	+49,93%	409,07 Md
Moyenne pondérée par Capi.	-0,76%	-1,92%	+38,68%	+65,95%